Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference
30 Juillet 2024 - 10:05PM
Business Wire
Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or
the “Company”), The Protein Sequencing CompanyTM, today announced
that it will be participating in the Canaccord Genuity 44th Annual
Growth Conference taking place in Boston August 13-15, 2024.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, and Jeff
Keyes, Chief Financial Officer, will participate in a fireside chat
on Tuesday, August 13th, at 11:00 AM ET.
A live and archived webcast of the event will be available in
the “Investors” section of the Quantum-Si website under Events
& Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on
revolutionizing the growing field of proteomics. The Company's
suite of technologies is powered by a first-of-its-kind
semiconductor chip designed to enable next-generation
single-molecule protein sequencing and digitize proteomic research
in order to advance drug discovery and diagnostics beyond what has
been possible with DNA sequencing. Learn more at quantum-si.com or
follow us on LinkedIn or X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240730798589/en/
Investor Contact Doug Farrell, VP, Investor Relations
ir@quantum-si.com Media Contact Katherine Atkinson, SVP of
Commercial Marketing media@quantum-si.com
Quantum Si (NASDAQ:QSI)
Graphique Historique de l'Action
De Août 2024 à Sept 2024
Quantum Si (NASDAQ:QSI)
Graphique Historique de l'Action
De Sept 2023 à Sept 2024